Elwyn was very active in bringing pulmonary fibrosis medications to patients, spending substantial amounts of his own time and money. From that experience, he w

Elwyn was very active in bringing pulmonary fibrosis medications to patients, spending substantial amounts of his own time and money. From that experience, he was interested in how novel clinical trial designs could assess the effectiveness of therapies faster for patients while controlling for bias and luck.